We are excited to announce that Arithmos will be joining the World Patient Safety Congress (WPSC) 2026, exhibiting alongside Epiqure, our recently acquired Quality and Compliance specialist, now an Arithmos company.
WPSC brings together healthcare professionals, regulators and life sciences experts from across the industry to focus on one goal: improving patient safety. With pharmacovigilance at the heart of that mission, it’s the natural place for Arithmos and Epiqure to introduce our joint offering in PV Quality, Technology and Services, for the first time.
WPSC 2026 event information
- Event format: Face-to-Face
- Dates: 23-24 September 2026
- Event location: Amsterdam, RAI
- Stand location: Stand 402, on Epiqure’s booth
Joining forces with Epiqure
In May 2026, Arithmos announced the acquisition of Epiqure, a global provider of GxP Quality Assurance, Compliance, and Technology services. The acquisition strengthens Arithmos’s GVP, GCP and GMP Quality Assurance capabilities and expands its geographic reach and client base across Europe, particularly in France and Switzerland.
“Epiqure is an excellent fit for Arithmos, enlarging our GxP Quality Assurance services,” said Arithmos CEO Paolo Morelli. “The acquisition brings additional highly talented professionals into our organisation and enhances the value we deliver to clients through a broader European presence.”
At WPSC, you’ll find us on Epiqure’s stand, where we’ll be sharing more about what this means for clients: a single partner with a relevant GVP Quality expertise, an enormous range of GxP and Technology services and a stronger presence across Europe.
About Arithmos
With deep expertise in the Life Science Industry, Arithmos supports companies in their digital transformation journey to achieve the best value from technology-enabled solutions and excellence in business operations.
Arithmos team share extensive knowledge of the full GxP regulated environment for both deliveries of services and technologies, and our domains range from Clinical Development, Quality & Compliance, Pharmaco-Vigilance & Safety and, Regulatory Affairs.
